Impact Assessment of Cancer Treatment Support Program

This report presents an impact assessment of the Cancer Treatment Support Program initiated by ICICI Securities in collaboration with Tata Memorial Centre. The primary objective of the program is to provide treatment support to cancer patients from lower income groups who lack the means for ongoing treatment. The assessment outlines the methodology used, including qualitative data collection and stakeholder interviews, to evaluate the program's effectiveness and relevance. Key findings indicate that 234 patients received support, with 41% completing their treatment. The report details the types of treatments funded, including chemotherapy, surgery, and radiotherapy, and emphasizes the program's role in enhancing the quality of life for patients. The assessment also highlights the inclusiveness of the program, ensuring equitable access to treatment for all eligible patients. Furthermore, it discusses the alignment of the program with Sustainable Development Goals and ESG principles, underscoring its significance in improving health outcomes for underserved communities.